The domestic registration of Ampicillin API of The United Laboratories (Inner Mongolia) Co., Ltd. wa

Recently, the domestic registration of Ampicillin API of The United Laboratories (Inner Mongolia) Co., Ltd. successfully passed the technical review of the Drug Evaluation Center of the State Drug Administration (CDE), and was approved by the State Drug Administration (NMPA). The original package publicity platform of CDE was changed from "I" to "A". The approval of Ampicillin enriches the variety of raw materials of Inner Mongolia Company, helps to further expand domestic and international markets, and can bring considerable economic benefits to enterprises.